Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort

BACKGROUND: Sorafenib is the current standard of care for patients with advanced or metastatic hepatocellular carcinoma. Currently no universally agreed model exists correlating the Neutrophil Lymphocyte ratio (NLR) and non-secretion of AFP with the survival of HCC patients treated with sorafenib. P...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Afshar, Mehran, Fletcher, Peter, Bardoli, Antonio D, Ma, Yuk Ting, Punia, Pankaj
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2018
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908300/
https://ncbi.nlm.nih.gov/pubmed/29682199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24769
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki